• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Can J Respir Ther . Clinical predictors of impaired pulmonary diffusing capacity in patients recovering from COVID-19: A secondary analysis of mult

tetano

Editor, Senior Moderator
Can J Respir Ther


. 2026 Jul 14:62:127-134.
doi: 10.29390/001c.164115. eCollection 2026.
Clinical predictors of impaired pulmonary diffusing capacity in patients recovering from COVID-19: A secondary analysis of multicentre datasets

Patchareeya Amput[SUP] 1 [/SUP], Weerasak Tapanya[SUP] 1 [/SUP], Noppharath Sangkarit[SUP] 1 [/SUP], Suphannika Ladawan[SUP] 1 [/SUP], Sirima Wongphon[SUP] 2 [/SUP]


Affiliations
Abstract

This study aimed to identify clinical predictors of impaired pulmonary diffusing capacity in patients recovering from coronavirus disease 2019 (COVID-19) using a secondary analysis of multicentre datasets. # Methods This secondary analysis included adults with laboratory-confirmed COVID-19 who underwent pulmonary function testing during the post-acute recovery phase. In total, 572 post-COVID-19 patients were included. Demographic characteristics and pulmonary function parameters were extracted from the datasets. Impaired pulmonary diffusing capacity for carbon monoxide (DLCO) was defined as a DLCO Z-score < -1.645 (below the lower limit of normal) according to Global Lung Function Initiative reference equations. Univariable logistic regression was used as an initial screening step, and variables with p < 0.10, together with clinically relevant variables, were considered for multivariable analysis. # Results Of the 572 post-COVID-19 patients, 145 had impaired DLCO. Baseline characteristics differed significantly between patients with normal and impaired DLCO, particularly in age, sex, forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and total lung capacity (TLC) (p < 0.05). Age, sex, FVC, FEV1, and TLC were significantly associated with impaired DLCO in multivariable analysis. In multivariable logistic regression, age (adjusted OR 1.025; p = 0.002), female sex (adjusted OR 0.379; p < 0.001), and TLC (adjusted OR 0.603; p < 0.001) remained statistically associated with impaired DLCO. The model showed acceptable apparent discrimination in the development dataset (AUC 0.710). # Conclusions Impaired pulmonary diffusing capacity was observed in approximately one-quarter of patients recovering from COVID-19. Older age, sex, and lower total lung capacity were independently associated with impaired DLCO in this secondary analysis. These findings should be interpreted as exploratory associations rather than causal or validated predictive effects.

Keywords: COVID-19; DLCO; diffusion capacity; pulmonary function; spirometry.

 
Back
Top